The favorable dismissal removes a class-action overhang. With market cap of $125B and no material financial impact even in a worst-case scenario, this ruling is a modest positive, but not a price catalyst. Monitor for appeals, though dismissal with prejudice and no leave to amend makes appellate success unlikely. The ruling does not affect Stryker's ability to use non-compete agreements for higher-compensated employees.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 27 $387.46entry
- T+1 · 9mo ago −0.11%α −0.17% · $387.02
- T+5 · 9mo ago −5.91%α −3.93% · $364.56
- T+20 · 8mo ago −15.49%α −7.92% · $327.44
- T+60 · 6mo ago −19.22%α −28.63% · $313.00
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The court dismissed with prejudice a proposed class action against Stryker Corp alleging that the company violated Washington's Noncompetition Covenant Act by requiring low-earning sales representatives to sign non-compete agreements. The ruling held that the statute does not prohibit requiring employees to sign such agreements, it merely renders them unenforceable if certain conditions are not met. This eliminates a potential class-action litigation risk for Stryker with no damages paid and no ongoing exposure.
Court Ruling Details
Key Facts
- Case Belleque v. Stryker Corporation dismissed with prejudice under Rule 12(b)(6) for failure to state a claim
- Plaintiff sought $5,000 statutory damages per class member plus an injunction against Stryker's use of non-compete agreements
- Court ruled that Washington's Noncompetition Covenant Act does not prohibit requiring new employees to sign non-compete agreements, it only renders them void/unenforceable below a salary threshold
- No damages awarded; case closed without leave to amend
- Stryker's separate motion to bifurcate discovery denied as moot
Financial Impact
No damages awarded; potential class-wide exposure eliminated (statutory damages of $5,000 per class member plus attorneys' fees, no class ever certified, case dismissed at pleading stage)
Risk Factors
- Plaintiff could appeal to the Ninth Circuit, though appeal prospects appear low given the clear statutory interpretation
- Pending Washington Senate Bill 5437 could alter the legal landscape for non-compete agreements if enacted, potentially reopening exposure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-2qlj3rzv-SYK |
Track record
29 reports on SYK
5 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 7 of 10 went positive at some point.
Filters
- Nov 12, 20266d ago Court Ruling Neutral 3/10 Entry $309.64 Now $310.72 +0.35% settles Dec 14
- Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
- Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
- Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
- Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
- Oct 29, 202619d ago 8-K Bearish 6/10 No price data
- Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
- Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
- Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
- Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers